FARFETCH LTD's ticker is and the CUSIP is 30744WAD9. A total of 33 filers reported holding FARFETCH LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,908,130 | -18.2% | 33,392,000 | +24.4% | 0.42% | -1.7% |
Q2 2023 | $21,901,424 | +25.7% | 26,832,000 | +20.7% | 0.42% | +28.5% |
Q1 2023 | $17,423,473 | +389.8% | 22,238,000 | +457.3% | 0.33% | +423.8% |
Q2 2022 | $3,557,000 | -59.6% | 3,990,000 | -40.9% | 0.06% | -55.3% |
Q1 2022 | $8,801,000 | +169.7% | 6,750,000 | +575.0% | 0.14% | +123.8% |
Q2 2021 | $3,263,000 | – | 1,000,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Marcho Partners LLP | 40,000,000 | $21,450,000 | 6.65% |
DeepCurrents Investment Group LLC | 28,682,000 | $15,585,309 | 0.68% |
AQR Arbitrage LLC | 25,500,000 | $13,675,650 | 0.61% |
ADVENT CAPITAL MANAGEMENT /DE/ | 33,392,000 | $17,908,130 | 0.42% |
LMR Partners LLP | 45,000,000 | $23,962,500 | 0.27% |
Context Capital Management, LLC | 4,000 | $2,161 | 0.17% |
Calamos Advisors LLC | 23,171,000 | $12,476,657 | 0.06% |
Patient Capital Management, LLC | 2,000,000 | $1,093,850 | 0.06% |
Verition Fund Management LLC | 9,044 | $4,850,297 | 0.06% |
Opti Capital Management, LP | 1,000,000 | $549 | 0.04% |